Myriad Receives FDA Approval of BRACAnalysis CDx® as a Companion Diagnostic for Lynparza® in HRR-mutated Metastatic Castration-Resistant Prostate Cancer

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy